People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CoreLab Partners, Inc. | — | Biotechnology | Series A | $15.7M | $315.0M | 2010 |
| Biomedical Structures Holding Corp. | — | Other | Seed | $3.8M | $69.7M | 2010 |
| Cequent Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $2.7M | $100.9M | 2009 |
Herbert H. Hooper at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Herbert H. Hooper on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eugene D. Hill | 1 | 5 |
| Peter D. Parker | 1 | 3 |
| Lauren H. Silverman | 1 | 2 |
| Richard A. Charpie | 1 | 2 |
| Denis J. Manginelli | 1 | 2 |
| Michael Woehler | 1 | 1 |
| Andrew T. Jay | 1 | 1 |
| Suzanne E. MacCormack | 1 | 1 |
| John Gray | 1 | 1 |
| Todd Rainville | 1 | 1 |
| Robert H. Miniutti | 1 | 1 |
| Michael H. Taylor | 1 | 1 |
| Eric H. Linsley | 1 | 1 |
| Thomas H. Hancock | 1 | 1 |
| Chiang D. Li | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.